首页> 外文学位 >Patient Derived Xenograft Models of Small-cell Lung Cancer Provide Molecular Insights into Mechanisms of Chemotherapy Cross-resistance

【24h】

Patient Derived Xenograft Models of Small-cell Lung Cancer Provide Molecular Insights into Mechanisms of Chemotherapy Cross-resistance

机译：小细胞肺癌的患者衍生异种移植模型为化学疗法交叉耐药机制提供分子见解

获取原文

获取原文并翻译 | 示例

页面导航

著录项
相似文献
相关主题

著录项

作者
Myers, David T.;
展开▼
作者单位

Boston University.;

展开▼
授予单位 Boston University.;
学科
学位 M.S.
年度 2018
页码 69 p.
总页数 69
原文格式 PDF
正文语种 eng
中图分类
关键词
入库时间 2022-08-17 11:59:34

相似文献

外文文献
中文文献
专利

1. Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancer [J] . Zhijie Wang, Shuai Fu, Jun Zhao, Cancer letters . 2019,第期

机译：跨脉络镜患者活组织检查衍生的异种移植物作为探索细胞肺癌的化学惯性相关途径和生物标志物的临床前模型
2. Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy? [J] . Merk J, Rolff J, Becker M European journal of cardio-thoracic surgery: Official journal of the European Association for Cardio-thoracic Surgery . 2009,第3期

机译：非小细胞肺癌患者来源的异种移植：评估辅助化疗的临床前模型？
3. Temozolomide plus PARP Inhibition in Small-Cell Lung Cancer: Could Patient-Derived Xenografts Accelerate Discovery of Biomarker Candidates? [J] . Pacheco Jose M., Byers Lauren Averett Cancer discovery. . 2019,第10期

机译：小细胞肺癌中的替莫唑啉代加PARP抑制：患者衍生的异种移植物可以加速生物标志物候选者的发现吗？
4. Molecular Characterization of Circulating Tumor Cells Enriched by a Microfluidic Platform in Patients with Small-Cell Lung Cancer [C] . Robert Zeilinger International Molecular Medicine Tri-Conference. . 2019

机译：小细胞肺癌患者微流体平台富集的循环肿瘤细胞的分子表征
5. Comparing gene expression profiles of cell culture models with profiles of tumor xenografts and patient tumors: Implications for lung and breast cancers. [D] . Creighton, Chad J. 2006

机译：将细胞培养模型的基因表达谱与异种移植瘤和患者肿瘤谱进行比较：对肺癌和乳腺癌的影响。
6. PCLN-06. NOVEL TUMOR-DERIVED MODELS OF CNS HGNET-BCOR PROVIDE INSIGHTS INTO UNDERLYING MOLECULAR MECHANISMS AND INNOVATIVE THERAPEUTIC OPTIONS [O] . Johannes Gojo, Dominik Kirchhofer, Daniela Lötsch, 2018

机译：PCLN-06。新型的CNS HGNET-BCOR的肿瘤衍生模型提供了对分子机制和创新治疗方案的深入了解
7. Temozolomide plus PARP Inhibition in Small-Cell Lung Cancer: Could Patient-Derived Xenografts Accelerate Discovery of Biomarker Candidates? [O] . Jose M. Pacheco, Lauren Averett Byers 2019

机译：小细胞肺癌中的替莫唑啉代加PARP抑制：患者衍生的异种移植物可以加速生物标志物候选者的发现吗？

Patient Derived Xenograft Models of Small-cell Lung Cancer Provide Molecular Insights into Mechanisms of Chemotherapy Cross-resistance

著录项

相似文献

相关主题

期刊订阅